Research AI tools—are they really just 'tools'?

AI for Science (AI4S) is widely recognized in academia as the fifth paradigm of scientific discovery, following experiments, theory, computation, and data-driven approaches. The global research system is undergoing profound changes. Traditional research mainly relies on human experience and a linear trial-and-error approach, but this pattern is being transformed and upgraded by an intelligent, closed-loop, collaborative human-AI R&D system.

When a biologist faces a new target, AI no longer just waits for instructions—it proactively gives suggestions: which sequences to analyze, which models to use, how to design experiments. This is not just a tool; it’s a collaborator integrated into the research process.

i. The paradigm shift of research tools: from passive execution to active collaboration

Human & AI Collaborative Interaction

The evolution of research tools can be roughly divided into two stages. The distinction isn’t based on technical complexity, but on how tasks are divided between humans and machines—who makes the decisions and who follows instructions.

The first stage is the tool-assisted paradigm. This is the classic way research has been done. Tools themselves have no cognitive ability and can only follow preset instructions. BLAST for sequence alignment, PyMOL for looking at structures, Python scripts for running statistics—every step requires humans to direct it. Choosing tools, setting parameters, verifying results, adjusting plans—all rely on the researcher’s personal experience. The whole process moves in a linear fashion: judge → tool executes → human judges again.

This model has been running for decades, and its efficiency is limited by the researcher’s energy and the speed of their experience accumulation.

But the explosive growth of data and the increasing complexity of research problems are forcing this model to upgrade. The second stage is already in practice—it can be called the human-machine collaborative paradigm. In April 2026, the Wuhan Artificial Intelligence Research Institute released the nation’s first full-process AI research agent, “ScienceClaw”. According to public reports, this agent has already been promoted in over a thousand organizations nationwide, serving more than 10,000 researchers. These agents are no longer limited to a single function—they can break down tasks, allocate resources, and integrate outputs based on research goals.

The key change isn’t that things are “faster,” but that they are now “participating.”

ii. Practical Applications: AI Agents Driving Upgrades in Protein Engineering Research

Order and Fragment Equilibrium

Protein engineering is one of the areas where AI4S has the most concentrated impact. The reason is easy to understand: complex structures, long iteration cycles, and high trial-and-error costs—these are exactly the scenarios where intelligent agents excel.

1. Conversational R&D Platform

In April 2026, Matwings Technology launched the conversational protein research AI MatwingsVenus™ (Xiaowu™) as a concrete example. This platform integrates tens of billions of real-labeled protein data, over 200 protein design tools, connects with more than 50 platform-certified domain experts, and features over 30 skill modules finely tuned by experts. Users can input task goals in natural language, and the system will automatically break down the tasks, schedule the corresponding design, prediction, analysis, and screening capabilities, and complete in-depth research, enzyme mining, directed evolution, de novo design, and automated collaboration on wet-lab experiments. Trial-and-error research, traditionally driven by experience, is gradually being replaced by predictable, iterative standardized workflows.

2. Closed Loop Linking Dry and Wet Labs

The automated connection between algorithm design and physical experiments is one of the most groundbreaking advances of AI in protein engineering. The biggest highlight of the MatwingsVenus™ (Xiaowu™) platform is breaking down the barrier between the digital and physical worlds, creating a "conversational dry-wet closed loop": after the agent completes a design, the platform can use a self-built communication mechanism to import results into plasmid ordering and experiment planning workflows, automatically link subsequent experimental tasks, and drive robots to complete sample preparation, protein purification, and functional testing. In May 2026, the platform’s "Protein Query" function received a major upgrade—providing one-stop access to over 30 mainstream bioinformatics databases, covering more than 400 professional analysis tools.

The key value of this model is not to replace a single step, but to compress the time from design to validation.

iii. Capability Limits of AI Research Tools: Value and Limitations

Tri-Panel Biotech Digital Pipeline

AI's capabilities are growing rapidly, but its limits are also clear. Clarifying what AI can and can't do is even more urgent than just improving computing power.

Where is it strong?

It stands out in integrating information. Parallel searches across databases, automatic literature review, building knowledge graphs—these tasks can now be done in hours, whereas they used to take days or even weeks. Task scheduling is also quite efficient. Faced with complex research goals, AI can break down tasks and utilize suitable algorithmic tools, cutting down the time humans spend on coordination. Plus, repetitive work like code debugging, data cleaning, and basic statistical analysis is gradually being taken over.

What can’t it do?

Original scientific hypotheses are still beyond AI's reach. Top-level design of research directions still relies on researchers’ intuition and judgment in their field. In terms of biological mechanism understanding, AI can currently handle large-scale data fitting and statistical analysis of explicit patterns, but it cannot independently combine long-accumulated domain knowledge to provide original explanations of biological mechanisms with research depth. The model's generalization is also limited by data quality—its predictive accuracy drops noticeably in data-scarce or frontier exploratory scenarios, still requiring human verification and correction.

The industry generally believes that smart technologies are pushing protein engineering toward standardization, but that doesn’t mean the entire process is automated. You can think of AI’s role like this—it handles all the standardized, repeatable basic work, while researchers focus on the core parts that require deep thinking and creativity. The boundary between the two will shift as technology advances, but it won’t disappear anytime soon.

iv. Industry Evolution Trend: Moving Towards a 'Research Partner'

The global AI4S technology iteration points to a common trend: AI is shifting from being an efficiency tool to becoming a deeply integrated 'research partner' in scientific workflows. This is precisely the core positioning of intelligent platforms like MatwingsVenus™ (XiaoWu™): not to replace scientists in doing research, but to be a 24/7 'research partner' by their side.

On the international level, tech giants are promoting the integrated application of AI tools in R&D scenarios, connecting multiple mainstream life science databases and gradually achieving an intelligent closed loop in research and development. The core of this model is not about 'speeding up,' but about human-AI collaboration—AI participates in experiment design, data integration, and iterative optimization, continuously adjusting subsequent strategies based on early data.

The essence of a 'research partner' lies in reallocating the work focus of researchers. When AI takes over tedious and repetitive tasks, researchers can free up their energy to focus more on exploring original scientific questions, constructing research logic, and planning cutting-edge directions—these are the parts of the research chain that are hardest to standardize and have the most long-term value.

V. Summary and Outlook

From executing instructions to human-machine collaboration, research tools have undergone a paradigm shift. In the field of protein engineering, the closed-loop dry-wet integrated R&D system has initially proven its feasibility—issues like low efficiency and high costs in traditional R&D are gradually being addressed by this model.

Currently, AI research tools are still limited by the generalization ability of models, and their adaptation accuracy in complex scenarios hasn't reached a stable level yet. But as underlying models keep evolving, biological databases continue to expand, and the dry-wet integrated system matures, the specialization of AI research agents will further improve.

The foreseeable outcome is that human-machine collaboration will become the industry norm. AI will keep empowering standardized processes, while humans focus on cutting-edge innovation and key decisions. Each will handle what they’re best at, jointly driving technological breakthroughs and industrial upgrades in the life sciences field.